CTRI/2020/12/030072进行中（未招募）未知
Targeting de novo Pyrimidine Biosynthesis by leflunomide as a Novel Concept for the Treatment of Corona Virus Disease 2019 (COVID-19) - DEFEAT-COVID
Research and Development Department RD0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age >=18 years
- •2. Patients with onset of symptoms ï?£15 days
- •3. Laboratory (RT-PCR) confirmed infection with 2019-nCoV.
排除标准
- •1. Pregnant or breast feeding;
- •2. On specific monoclonal antibodies, or other drug trial treatment for COVID-19 within one week prior to study enrolment;
- •3. Liver function tests >2 fold of upper limits of normal (ULN) reference levels of the respective testing assay.
- •4. Patients with known hypersensitive to leflunomide
- •5. Patients with severe immunodeficiency syndrome and hypoalbuminaemia.
研究者
相似试验
进行中（未招募）
1 期
DEFEAT-COVID StudyEUCTR2020-002952-18-GBAshford and St Peter's Hospitals NHS Foundation Trust178
尚未招募
Unknown
nderstanding the role of pyrimidine compound in breast cancerCTRI/2023/11/059474PRAMOD KUMAR AVTI
尚未招募
不适用
Improving the safety of fluoropyrimidine-based chemotherapy by combined DPYD genotype-guided and DPD phenotype-guided dose individualisation: The Alpe2U studycolorectal cancerNL-OMON49970Antoni van Leeuwenhoek Ziekenhuis1,440
招募中
不适用
Demonstrating Pemetrexed induced Thymidylate Synthase inhibition in non-small cell lung cancer in vivo: a pilot study.10038666NSCLCNL-OMON32208Vrije Universiteit Medisch Centrum12
尚未招募
不适用
Identification of the mechanisms of 5-fluorouracil (5-FU)-induced Gastrointestinal (GI) toxicity in human coloNL-OMON26903Maastricht University20